📖
Occurrence and number of immune-related adverse events are independently associated with survival in advanced non-small-cell lung cancer treated by nivolumab
Linda Bouhlel, Jérôme Doyen, Emmanuel Chamorey, Michel Poudenx, Marius Ilie, Jocelyn Gal, Joël Guigay, Jonathan Benzaquen, Charles-Hugo Marquette, Jean-Philippe Berthet, Jérôme Mouroux, Renaud Schiappa, Bernard Padovani, Paul Hofman, Josiane Otto

Occurrence and number of immune-related adverse events are independently associated with survival in advanced non-small-cell lung cancer treated by nivolumab

Science & Mathematics Published 2020 Verification Pending
Indexed from repository: HAL Open Science (hal.science)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Occurrence and number of immune-related adverse events are independently associated with survival in advanced non-small-cell lung cancer treated by nivolumab
Author / Organization Linda Bouhlel, Jérôme Doyen, Emmanuel Chamorey, Michel Poudenx, Marius Ilie, Jocelyn Gal, Joël Guigay, Jonathan Benzaquen, Charles-Hugo Marquette, Jean-Philippe Berthet, Jérôme Mouroux, Renaud Schiappa, Bernard Padovani, Paul Hofman, Josiane Otto
Subject & Discipline Multidisciplinary Academic Open Research
Categories Science & Mathematics
Publication Year 2020
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website HAL Open Science (hal.science)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-172696
Original Source Link Visit Source Page on hal.science »